Downregulation of protocadherin-10 expression correlates with malignant behaviour and poor prognosis in human bladder cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Downregulation of protocadherin-10 expression correlates with malignant behaviour and poor prognosis in human bladder cancer
Authors
Keywords
-
Journal
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
Volume 41, Issue 1, Pages 38-47
Publisher
SAGE Publications
Online
2013-01-24
DOI
10.1177/0300060513476989
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Significance of CDH13 Promoter Methylation in Serum Samples from Patients with Bladder Transitional Cell Carcinoma
- (2013) YL Lin et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- The Significance of Fragile Histidine Triad Protein as a Molecular Prognostic Marker of Bladder Urothelial Carcinoma
- (2013) CT Zhang et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Predictive factors for recurrence progression and cancer specific survival in high-risk bladder cancer
- (2012) Oscar Rodríguez Faba et al. CURRENT OPINION IN UROLOGY
- Strategies to prevent progression of high-risk bladder cancer at initial diagnosis
- (2012) Ja H. Ku et al. CURRENT OPINION IN UROLOGY
- Protocadherin-10 is involved in angiogenesis and methylation correlated with multiple myeloma
- (2012) YING LI et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Bladder Wash Cytology at Diagnosis of Ta-T1 Bladder Cancer Is Predictive for Recurrence and Progression
- (2012) Georg Jancke et al. UROLOGY
- Role of PCDH10 and its hypermethylation in human gastric cancer
- (2011) Zesong Li et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Epigenetic inactivation ofPCDH10in human prostate cancer cell lines
- (2011) Zesong Li et al. CELL BIOLOGY INTERNATIONAL
- PCDH10 is a candidate tumour suppressor gene in medulloblastoma
- (2011) Kelsey C. Bertrand et al. CHILDS NERVOUS SYSTEM
- Bladder cancer
- (2011) Todd M Morgan et al. CURRENT OPINION IN ONCOLOGY
- Identification and characterization of human PCDH10 gene promoter
- (2011) Zesong Li et al. GENE
- Promoter methylation of H-cadherin is a potential biomarker in patients with bladder transitional cell carcinoma
- (2011) Ying-Li Lin et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Clinical Significance of T-Cadherin Tissue Expression in Patients with Bladder Transitional Cell Carcinoma
- (2011) YingLi Lin et al. UROLOGIA INTERNATIONALIS
- Bladder Cancer in 2010: How Far have We Come?
- (2010) B. L. Jacobs et al. CA-A CANCER JOURNAL FOR CLINICIANS
- High-resolution melting analysis of PCDH10 methylation levels in gastric, colorectal and pancreatic cancers
- (2010) B. Yu et al. NEOPLASMA
- Field methylation silencing of the protocadherin 10 gene in cervical carcinogenesis as a potential specific diagnostic test from cervical scrapings
- (2009) Kai-Hung Wang et al. CANCER SCIENCE
- Declaration of Helsinki, 2008: Implications for stakeholders in research
- (2009) UM Thatte et al. Journal of Postgraduate Medicine
- The present and future burden of urinary bladder cancer in the world
- (2009) Martine Ploeg et al. WORLD JOURNAL OF UROLOGY
- Methylation of Protocadherin 10, a Novel Tumor Suppressor, Is Associated With Poor Prognosis in Patients With Gastric Cancer
- (2008) Jun Yu et al. GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now